大名城(600094.SH):擬斥2億元-4億元回購公司股份
格隆匯4月5日丨大名城(600094.SH)公佈關於以集中競價交易方式回購股份的方案的公吿,此次回購擬使用資金總額為不低於人民幣2億元且不超過人民幣4億元。具體回購股份的金額以回購期滿時實際回購股份的金額為準。
回購價格不超過人民幣5.76元/股。具體回購的價格將在回購實施期間結合公司股票價格、財務狀況和經營狀況確定。
回購股份用途為“為維護公司價值及股東權益所必需”,所回購股份將用於註銷及出售,其中擬用於減少註冊資本的註銷及用於二級市場出售的股份數額,分別不超過此次回購股份總數額的二分之一。回購期限自公司董事會審議通過回購方案之日起不超過3個月。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.